Crossmark

PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study

Crossref DOI link: https://doi.org/10.1136/openhrt-2021-001630

Published Online: 2021-10-20

Published Print: 2021-10

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Hobbs, FD Richard https://orcid.org/0000-0001-7976-7172
Hussain, Rizwan I

Vitale, Cristina

Pinto, Yigal M

Bueno, Hector

Lequeux, Benoit

Pauschinger, Matthias

Obermeier, Michael

Ferber, Philippe C

Gustafsson, Finn
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02807857 at ClinicalTrials.gov

Documents that mention this clinical trial

PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study
https://doi.org/10.1136/openhrt-2021-001630
Funding

Funding for this research was provided by:

Novartis Pharma
License Information

License valid from 2021-10-19